Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Lythgoe

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Prostate Cancer and Prostatic Diseases|October 5, 2023
Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
The Lancet. Oncology|May 4, 2023
The rise of immuno-oncology in China: a challenge to western dominance?Mark P Lythgoe, Grant Lewison, Ajay Aggarwal, et al.
JAMA Network Open|June 10, 2022
Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019Mark P Lythgoe, Aakash Desai, Bishal Gyawali, et al.
Cancers|August 27, 2021
Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine NeoplasiaRebecca Abdelmalak, Mark P Lythgoe, Joanne Evans, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Cancer Investigation|October 5, 2022
Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020Ryan S Chiang, Aakash Desai, Michael J Glover, et al.
Non-Coding RNA|August 25, 2022
Polymeric Carriers for Delivery of RNA Cancer TherapeuticsSofía Mirón-Barroso, Joana S Correia, Adam E Frampton, et al.
International Journal of Cancer|February 13, 2023
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020Viktoria Gloy, Andreas M Schmitt, Pascal Düblin, et al.
British Journal of Cancer|November 26, 2022
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspectiveSarah P Blagden, Ly-Mee Yu, Stephanie Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Prostate Cancer and Prostatic Diseases|October 5, 2023
Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.
The Lancet. Oncology|May 4, 2023
The rise of immuno-oncology in China: a challenge to western dominance?Mark P Lythgoe, Grant Lewison, Ajay Aggarwal, et al.
JAMA Network Open|June 10, 2022
Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019Mark P Lythgoe, Aakash Desai, Bishal Gyawali, et al.
Cancers|August 27, 2021
Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine NeoplasiaRebecca Abdelmalak, Mark P Lythgoe, Joanne Evans, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Cancer Investigation|October 5, 2022
Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020Ryan S Chiang, Aakash Desai, Michael J Glover, et al.
Non-Coding RNA|August 25, 2022
Polymeric Carriers for Delivery of RNA Cancer TherapeuticsSofía Mirón-Barroso, Joana S Correia, Adam E Frampton, et al.
International Journal of Cancer|February 13, 2023
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020Viktoria Gloy, Andreas M Schmitt, Pascal Düblin, et al.
British Journal of Cancer|November 26, 2022
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspectiveSarah P Blagden, Ly-Mee Yu, Stephanie Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Pageof 7